Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
Insulet posted revenues of $226.30 million for the quarter ended June 2020. This compares to year-ago revenues of $177.14 million.
If you found this site useful and want to help keep it alive,
to cover the costs and keep the site free of advertisements! Thank you for your support!